Lawmakers led by Rep. Greg Murphy, MD, R-N.C., are reintroducing the Provider Reimbursement Stability Act of 2026, which is endorsed by the AMA and MGMA.
U.K.-based Lucida Medical’s diagnostic tool is already deployed by the NHS, with the company earmarking the funds for the pursuit of regulatory approval in the U.S.
Patients with coronary artery disease and severe aortic stenosis often undergo PCI before TAVR. According to new data presented at ACC.26, however, deferring PCI is associated with comparable outcomes as well as a reduced bleeding risk.
New findings from a large CT lung cancer screening dataset reveal that a substantial number of patients have significant incidental findings visible on their scans.
A new review of the relevant scientific literature suggests many if not most patients are aware that healthcare AI’s emerging benefits exist side-by-side with its persistent uncertainties.
Among healthcare organizations sweating the possible passage of the “One Big Beautiful Bill,” few have more to worry about than nonprofit hospitals and health systems that compete with privately held or publicly traded rivals for executive talent.
Lawmakers led by Rep. Greg Murphy, MD, R-N.C., are reintroducing the Provider Reimbursement Stability Act of 2026, which is endorsed by the AMA and MGMA.
